Company / Current Assets
Catalyst Pharmaceuticals Partners, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$894.0M
FY2025
5-year range
$210.1M / $894.0M
FY2021-FY2025
Trend
+43.4%
vs FY2024
Sector context
#63 of 213
Health Care
What the data says
At $894M, Catalyst Pharmaceuticals Partners, Inc.'s current assets ranks #63 of 213 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $41M in FY2016 to $894M in FY2025.
Based on SEC 10-K filings.
$894M in FY2025 with a 5-year CAGR of +41.2%.
Improved from $219M to $894M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +40.7%
- 5-Year CAGR
- +41.2%
- 10-Year CAGR
- -
Sector benchmark
#63 of 213 in Health CareTop 30% of 213This company $894.0M Sector average $2.5B
▼
-64.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +41.2%, indicating consistent growth.
- In FY2025, current assets increased 43.4% year-over-year.
- Ranks #63 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $894.0M | +43.4% |
| FY2024 | $623.6M | +184.3% |
| FY2023 | $219.3M | -31.6% |
| FY2022 | $320.8M | +52.7% |
| FY2021 | $210.1M | +31.9% |
| FY2020 | $159.2M | +43.0% |
| FY2019 | $111.4M | +101.8% |
| FY2018 | $55.2M | -35.2% |
| FY2017 | $85.2M | +105.5% |
| FY2016 | $41.5M | -30.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026